Cholesterol Crystal Dissolution Rate of Serum Predicts Outcomes in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
Baravan Al-KassouLara Al-KassouThorsten MahnDieter LütjohannJasmin ShamekhiNicola WillemsenSven Thomas NiepmannStephan BaldusMalte KelmGeorg NickenigEicke LatzSebastian ZimmerPublished in: Journal of the American Heart Association (2024)
The CCDR is a novel biomarker associated with outcome in patients with aortic stenosis undergoing transcatheter aortic valve replacement. It may provide new insights into patients' anti-inflammatory capacity and additional prognostic information beyond classic risk assessment.
Keyphrases
- aortic stenosis
- transcatheter aortic valve replacement
- ejection fraction
- aortic valve replacement
- aortic valve
- transcatheter aortic valve implantation
- risk assessment
- end stage renal disease
- left ventricular
- anti inflammatory
- newly diagnosed
- chronic kidney disease
- coronary artery disease
- prognostic factors
- type diabetes
- peritoneal dialysis
- heavy metals
- heart failure
- metabolic syndrome
- human health
- social media
- skeletal muscle
- weight loss